Personal record-keeping and educational reference. 18+. The app does not recommend substances, doses or treatment, or determine whether a substance is safe, approved or appropriate for you. Consult a qualified healthcare professional about decisions involving your health.
‹ Library

PNC-27

Research (Other)Research Use Only

Also known as: p53-derived peptide

An experimental peptide designed to target cancer-cell membranes — no human trials; FDA has warned about unapproved sales.

Dosing quick reference

research reference
Starting dose
100 mcg once daily
Frequency
Once daily
Typical range
100–500 mcg per day
Cycle
8–12 weeks
Titration (step-up)
Increase ~100 mcg every 2 weeks: 100 → 500 mcg
No human clinical trials exist; FDA has flagged PNC-27 products as unapproved.
Half-life
Not well characterized
Route
Research use in laboratory models
Common use
Preclinical cell-membrane research
Common vial sizes
30 mg
Storage
Store lyophilized powder frozen; after reconstitution refrigerate at 2-8°C and use within a short window.

Reported side effects

Limited to preclinical data; human safety not established
Calculate a dose →

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Research-only labeling does not establish that a substance is safe, approved or appropriate for personal use. Consult a qualified healthcare professional about health decisions.